Biomedical Research Has Support, But Questions Linger About Funding

Credit: Depositphotos image_5645691_chepko

initiative. The company started out making rheostats and other devices for cranes and other machines used in building construction. Over the years, though, its operations have expanded; on its website, Rockwell says it sells to organizations that manufacture pharmaceuticals, medical devices, and lab equipment.

“This is literally a life-changing approach and adds a new chapter to medicine,” says Blake Moret, the company’s CEO, in a prepared statement. “Our contribution is to integrate biomanufacturing science with production techniques that increase the capacity, speed, modularity, and consistent quality of new tissue and organ production.”

Author: Jeff Buchanan

Jeff formerly led Xconomy’s Seattle coverage since. Before that, he spent three years as editor of Xconomy Wisconsin, primarily covering software and biotech companies based in the Badger State. A graduate of Vanderbilt, he worked in health IT prior to being bit by the journalism bug.